All Pharma articles – Page 41
-
HSJ KnowledgeHow PCTs can involve the public in funding decisions
The public may still be reticent about getting involved in decision making about drug and treatment funding but PCTs are expected to engage them. Lynne Greenwood reports
-
News
DH rewrites top-ups guidance
The Department of Health has rewritten its guidance on co-payments following fears of increased bureaucracy for primary care trusts and hospitals.
-
NewsWeak pound triggers pharmaceutical supply shortages
Pharmacists could ask the Department of Health to reopen negotiations on their contract following supply shortages triggered by the pound’s low value.
-
HSJ KnowledgeAndrew Dillon on NICE guidance
Andrew Dillon explains how NICE guidance plans to eliminate variation in treatments and the reasons why there should be consistency
-
HSJ Knowledge
Alcohol screening at pharmacies boosts public health
Local pharmacy staff on the Wirral tactfully help people think about how much alcohol they drink, reports Lynne Greenwood
-
News
Mental health trust may scan for weapons and drugs
Airport style scanners for weapons and drugs could be installed in mental health wards, a leaked email seen by HSJ has revealed.
-
News
Sir Michael Rawlins reappointed NICE chair
Sir Michael Rawlins has been reappointed as chair of the National Institute for Health and Clinical Excellence after a special exemption to allow him to extend his tenure.
-
News
DH consults on speeding up drug decisions
Health minister Lord Darzi has launched a consultation designed to speed up access to new drugs and reduce variation between primary care trust areas.
-
News
NICE clarifies breast cancer guidance
The National Institute for Health and Clinical Excellence has re-worked its breast cancer guidelines in a bid to standardise care across the country.
-
HSJ KnowledgeWhy NICE values some patients' lives more
Mike Richards’ review of what to do about top-ups seems to reaffirm the line that the NHS should not subsidise private consumption of healthcare.
-
News
NICE lacks GP input says NHS Alliance
The NHS Alliance has given muted approval to Department of Health proposals to change the quality and outcomes framework GP bonus scheme.
-
News
NHS links to pharmaceutical industry raise suspicions, RCP warns
The medical profession needs to distance itself from the pharmaceutical industry to restore public confidence in the NHS, doctors have warned.
-
News
Government boosts flu pandemic drug stockpile
The government has awarded contracts to double supplies of antiviral drugs to treat pandemic flu.
-
News
Edwina Hart steals march on NICE with kidney drug decision
Welsh health minister Edwina Hart has angered some local health boards - and stepped further into NHS decision making - by ordering managers to pay for four unapproved drugs for advanced kidney cancer.
-
News
PCTs failing to involve public in drug decisions
Primary care trusts are failing to effectively involve the public in decisions over drugs not approved by the National Institute for Health and Clinical Excellence, according to a Picker Institute review.
-
News
NHS drug shortage looms as pound falls
The NHS could face a shortage of drugs because the weak pound means speculators are targeting UK pharmaceutical supplies for export to more lucrative markets.Data obtained by HSJ shows there has also been a dramatic slowdown in imports of cut-price branded drugs into the UK.
-
News
DH publishes reactions to pharmacy consultation
An analysis of responses to the Department of Health's proposals to improve pharmacy services has been published.
-
News
NICE backs changes to end of life drugs policy
The National Institute for Health and Clinical Excellence is to proceed with controversial plans to broaden access to drugs for terminally ill people.
-
News
New guidance on pharmaceutical needs assessments
NHS Employers has launched guidance for primary care trusts on how to develop pharmaceutical needs assessments in line with world class commissioning.
-
News
End of life drugs move raises budget concerns
The National Institute for Health and Clinical Excellence is to proceed with controversial plans to broaden access to drugs for the terminally ill in the face of serious concerns from health managers.